Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Warner Chilcott, historically known in part as Chilcott Laboratories, was a leading specialty pharmaceutical company focused on the women's healthcare, gastroenterology, dermatology, and urology markets. The company developed and commercialized a diverse portfolio of branded products, including well-known treatments such as Actonel for osteoporosis and Loestrin for contraception. Headquartered in Ireland with significant operations in the United States, the company grew through strategic acquisitions of product portfolios from larger firms like Procter & Gamble and Sanofi-Aventis. In 2013, Warner Chilcott was acquired by Actavis in a multi-billion dollar deal, which eventually became part of the Allergan and subsequently AbbVie corporate structures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chilcott Laboratories.